Perspectives on non-clinical safety evaluation of drug metabolites through the JSOT workshop
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-08-01
著者
-
Onodera Hiroshi
東京都健康安全研究センター
-
小野寺 博志
Division Of Pathology National Institute Of Health Sciences
-
Onodera H
Pharmaceuticals And Medical Devices Agency
-
Naito Shinsaku
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Furuta Shigeru
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Onodera Hiroshi
Dvision Of Pathology Biological Safety Research Center National Institute Of Health Sciences
-
Naito Shinsaku
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Onodera Hiroshi
Pharmaceutical And Medical Devices Agency
-
Naito Shinsaku
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
Minagawa Toshiya
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
Iwasa Takashi
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
Koga Toshihisa
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
NAKANO Kenji
Pharmaceuticals and Medical Devices Agency (PMDA)
-
FURUTA Shigeru
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
TAKEKAWA Koji
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
MINATO Kouichi
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
SATO Takashi
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
KAWASHIMA Kosuke
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
KURAHASHI Yoshikazu
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
NAKAMURA Kazuichi
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
Takekawa Koji
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
Minato Kouichi
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
Kurahashi Yoshikazu
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
Furuta Shigeru
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
Nakamura Kazuichi
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
Sato Takashi
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
関連論文
- Comparison of enhancing effects of different goitrogen treatments in combination with β-estradiol-3-benzoate for establishing a rat two-stage thyroid carcinogenesis model to detect modifying effects of estrogenic compounds
- LACK OF MODIFYING EFFECTS OF EUGENOL ON DEVELOPMENT OF LUNG PROLIFERATIVE LESIONS INDUCED BY URETHANE IN TRANS-GENIC MICE CARRYING THE HUMAN PROTOTYPE c-Ha-ras GENE
- Lack of Modifying Effects of Cinnamaldehyde on Development of Lung Proliferative Lesions Induced by Urethane in Transgenic Mice Carrying the Human Prototype c-Ha-ras Gene
- Inhibiting Effects of Ethinylestradiol on N-ethyl-M-nitrosourea-Initiated Uterine Carcinogenesis in Transgenic Mice Carrying a Human Prototype C-Ha-ras Gene (rasH2 mice) (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th A
- Promoting Effects of Ethinylestradiol but not Atrazine on N-ethyl-N-nitrosourea-induced Uterine Carcinogenesis in ICR Mice
- Difference in the Types of Uterine Tumors between Heterozygous p53-deficient and Wild Type CBA Mice Treated with Ethinylestradiol after N-ethyl-N-nitrosourea Initiation
- Modifying effect of atrazine on DMBA-induced mammary carcinogenesis in ovariectomized rats.(GENERAL SESSION BY POSTER PRESENTATION)(CARCINOGENICITY)
- A Preliminary Study of the Effect of Plantago Ovata Forsk on the Development of 7, 12-Dimethylbenz[a]anthracene-initiated Rat Mammary Tumors under the Influence of Hypercholesterolemia
- Modifying Effects of Genistein, 4-Nonylphenol and Methoxychlor on N-ethyl-N-nitrosourea-induced Uterine Carcinogenesis in RasH2 Transgenic Mice Harboring a Human Prototype C-Ha-ras Gene
- Enhancing Effects β-Estradiol 3-Benzoate but Not Methoxychlor on the Promotion/Progression Stage of Chemically-induced Mammary Carcinogenesis in Ovariectomized Rats
- GONADAL TOXICITY OF AN ETHANOL EXTRACT OF PSORALEA CORYLIFOLIA IN A RAT 90-DAY REPEATED DOSE STUDY
- The Utility of N-nitrosamines as Initiators for a 26-Week Rat Two-Stage Nasal Carcinogenesis Model
- Significance of Cyclin D1 Overexpression and K-ras Point Mutations in Lung Tumors Induced by N-methyl-N-nitrosourethane in Hamsters
- Effects of Simultaneous Treatment with Excess Amounts of Vitamin A and Goitrogens on Thyroid Tumorigenesis in Rats
- EFFECT OF SIMULTANEOUS TREATMENT OF LARGE AMOUNTS OF VITAMIN A AND THIOUREA ON THYROIDAL IODINE UPTAKE AND ORGANIFICATION IN RATS
- RELATIONSHIP BETWEEN PULMONARY FIBROSIS AND LUNG PROLIFERATIVE LESIONS INDUCED BY DIFFERENT DOSES OF N-METHYL-N-NITROSOURETHANE IN SYRIAN GOLDEN HAMSTERS
- ENHANCEMENT OF RAT THYROID PROLIFERATIVE LESION DEVELOPMENT BY STEP-WISE INCREASING DOSE TREATMENT WITH SULFADIMETHOXINE
- "C-6 Evaluation of Rat Hepatotoxicity on Benzimidazole Compounds Using Gap Junctional Intercellular Communication Protein, Connexin 32.
- Induction of Squamous Cell Carcinomas in the Salivary Glands of Rats by Potassium Iodide
- Possible enhancing effects of atrazine on growth of 7, 12-dimethylbenz(a) anthracene-induced mammary tumors in ovariectomized Sprague-Dawley rats
- Safety assessment of biopharmaceuticals : Japanese perspective on ICH S6 guideline maintenance
- Points to consider on the non-clinical safety evaluation of anticancer drugs
- CURRENT OPINION : SAFETY EVALUATION OF DRUG METABOLITES IN DEVELOPMENT OF PHARMACEUTICALS
- "POINTS TO CONSIDER" REGARDING SAFETY ASSESSMENT OF BIOTECHNOLOGY-DERIVED PHARMACEUTICALS IN NON-CLINICAL STUDIES (ENGLISH TRANSLATION)
- Current status of pharmaceutical industries in Japan on pharmacogenomics and toxicogenomics in 2005(Toxicogenomics, Toxicoproteomics, Proceedings of the 32nd Annual Meeting)
- S3-6 Problems and Meanings of Genome-based Drug Discovery in Japanese Pharmaceutical Companies(SYMPOSIUM 3: BENEFITS OF PHARMACOGENOMICS/PHARMACOGENETICS IN PHARMACEUTICAL DEVELOPMENT)(Proceedings of the 31st Annual Meeting)
- MECHANISTIC STUDY ON INHIBITION OF SERUM THYROID HORMONE PRODUCTION BY THIOUREA
- THYROID PROLIFERATIVE LESIONS INDUCED BY ANTI-THYROID DRUGS IN RATS ARE NOT ALWAYS ACCOMPANIED BY SUSTAINED INCREASES IN SERUM TSH
- TIME COURSE OBSERVATION OF THYROID PROLIFERATIVE LESIONS AND SERUM LEVELS OF RELATED HORMONES IN RATS TREATED WITH KOJIC ACID AFTER DHPN INITIATION
- IMMUNOHISTOCHEMICAL STUDIES OF TSH-PRODUCING CELLS IN THE PITUITARY AND EXPRESSION OF GROWTH FACTORS IN THYROIDAL PROLIF-ERATIVE LESIONS IN RATS TREATED WITH THIOUREA AND EXCESS VITAMIN A
- "P-42 Protective Effect of Lecithinization-Superoxide Dismutase Against Monocrotaline Induced Lung Injuries
- "P-41 A Morphometric study on the time course change of thyrotroph hypertrophy in the pituitary of rats treated with a goitrogen.
- Lack of Modifying Effects of NNK on Lung Tumorigenesis in Hamsters with Pulmonary Fibrosis Induced by MNUR
- DEVELOPMENT OF A TOXICOLOGIC PATHOLOGY SYSTEM USING PERSONAL COMPUTER NETWORK
- DOSE-THRESHOLD FOR THYROID TUMOR-PROMOTING EFFECTS OF ORALLY AMINISTERED KOJIC ACID IN RATS AFTER INITIATION WITH N-bis(2-HYDROXYPROPYL) NITROSAMINE
- CAPACITY FOR INDUCTION OF THYROID PROLIFERATIVE LESIONS BY ANTI-THYROID DRUGS WITH DIFFERENT TOXIC MECHANISMS
- TIME COURSE OBSERVATION OF THYROID PROLIFERATIVE LESIONS AND SERUM TSH LEVELS IN RATS TREATED WITH THIOUREA AFTER DHPN INITIATION
- RELATIONSHIP BETWEEN INDUCTION-DOSES OF THYROID TUMORS BY ANTI-THYROID DRUGS AND PLASMA LEVELS OF T_3, T_4 AND TSH
- Review of an alternative to animal testing for safety evaluation of Quasi-drug
- P-39 Effect of t-buthylhydroquinone and sodium nitrite alone or in combination on the forestomach of rasH2 mice.(Proceedings of the 27th Annual Meeting)
- P-38 Carcinogenic susceptibility of phenolphthalein in heterozygous p53 deficient C57BL/6 and CBA mice.(Proceedings of the 27th Annual Meeting)
- TOXICITY AND BLOOD CONCENTRATIONS OF XYLAZINE AND ITS METABOLITE, 2, 6-DIMETHYLANILINE, IN RATS AFTER SINGLE OR CONTINUOUS ORAL ADMINISTRATIONS
- 21C-11-2 Modifying Effects of Xylazine on Rat Nasal Carcinogenesis.
- 21WA-01-4 Modifying Effects of Endocrine Disrupting Chemicals to Thyroid Proliferative Lesions in Ovariectomized Rats.
- Absence of Tumor Promoting Activity of Xylazine in a Two-stage Nasal Carcinogenesis Model in N-bis(2-hydroxypropyl)nitrosamine-treated Rats
- O11-12 Modifying effects of endocrine disrupting chemicals on ENU-induced uterine carcinogenesis in heterozygous p53 deficient CBA mice.
- P-67 Early changes of thyroid and in rats given a single administration of diisopropanolnitrosamine.(Proceedings of the 27th Annual Meeting)
- O-14 Mechanistic studies on testicular toxicity of Psoralea corylifolia extract in rats.(Proceedings of the 27th Annual Meeting)
- 21C-10-3 Susceptibility of p53 heterozygous knockout CBA mice to carcinogenic substances.
- 3A-19 A Mechanistic Study on Ovarian Carcinogenesis of Nitrofurazone in Mice
- 3A-16 Toxicological significance of the metabolite, 2,6-xylidine, in rats treated with a parent drug, xylazine
- 3A-06 Study on the Thyroid Tumor Promotion Effect of Kojic Acid
- CONFIRMATION STUDY, USING NITROBENZENE, OF THE COMBINED REPEAT DOSE AND REPRODUCTIVE/DEVELOPMENTAL TOXICITY TEST PROTOCOL PROPOSED BY THE ORGANIZATION FOR ECONOMIC COOPERATION AND DEVELOPMENT (OECD)
- Prevention of Stroke by a Japanese Traditional Medicine, Shichimotsu-koka-to, in Stroke-Prone Spontaneously Hypertensive Rats-a Histopathological Study
- Preventive Effects of Shinchimotsu-koka-to on Renal Lesions in Stroke-Prone Spontaneously Hypertensive Rats
- MORPHOLOGICAL EVALUATION OF CYCLOPHOSPHAMIDE TESTICULAR TOXICITY IN RATS USING QUANTITATIVE MORPHOMETRY OF SPERMATOGENIC CYCLE STAGES
- TESTICULAR TOXICITY EVALUATION OF CYCLOPHOSPHAMIDE BY QUANTITATIVE MORPHOMETRY OF SPERMATOGENIC CYCLE STAGES
- EFFECTS OF BARBITAL ON NEURO-ONCOGENESIS IN A TRANSPLACENTAL CARCINOGENICITY MODEL USING F344 RATS
- STUDY OF EXAMINATION METHODS FOR ASSESSING MALE FERTILITY DISTURBANCES 1.QUANTITATIVE MORPHOMETRICAL EVALUATION OF TESTICULAR TOXICITY OF ADRIAMYCIN
- 遺伝子組換えとうもろこしCBH351のBNラット並びにB10Aマウスへの90日間混餌投与による免疫系への影響
- SPONTANEOUS MESOTHELIOMAS IN F344 RATS : A LIGHT AND ELECTRON MICROSCOPICAL STUDY
- Preclinical safety studies of anticancer agents : Cytotoxic agents(Breaking Through the Stage of Non-clinical to Clinical in the Drug Development Process, Proceedings of the 32nd Annual Meeting)
- S11-6 "6. Closing and Summary"(SYMPOSIUM 11: REGULATORY SCIENCE IN TOXICOLOGY RESEARCH : INTERPRETATION OF DEFINITION AND SIGNIFICANCE OF NOAEL (NON-OBSERVED ADVERSE EFFECT LEVEL) FOR PHARMACEUTICALS)(Proceedings of the 31st Annual Meeting)
- S11-1 Toxicology on Regulatory Sciences ; Interpretation of Definition and Signiflcance of NOAEL (No Observed Adverse Effect Level) for Pharmaceuticals(SYMPOSIUM 11: REGULATORY SCIENCE IN TOXICOLOGY RESEARCH : INTERPRETATION OF DEFINITION AND SIGNIFICANCE
- Prevention of Stroke by a Japanese Traditional Medicine, Shichimotsu-koka-to, in Stroke-Prone Spontaneously Hypertensive Rats : a Histopathological Study
- Perspectives on non-clinical safety evaluation of drug metabolites through the JSOT workshop
- Susceptibility of Heterozygous p53 Deficient CBA Mice to Induction of Liver Proliferative Lesions by Phenobarbital after Dimethylnitrosamine Initiation
- Modifying Effects of Endocrine Disrupting Chemicals on N-bis (2-hydroxypropyl) Nitrosamine and Sulfadimethoxine-Induced Thyroid Carcinogenesis in Rats
- Lack of Modifying Effects of Cinnamaldehyde on Development of Lung Proliferative Lesions Induced by Urethane in Transgenic Mice Carrying the Human Prototype c-Ha-ras Gene
- Modifying Effects of Flumequine on Dimethylnitrosamine-Induced Hepatocarcinogenesis in Heterozygous p53 Deficient CBA Mice
- Lack of Modifying Effects of Bisphenol A and Roasted-Ground Soybean (Kinako) on N-ethyl-N-nitrosourea-Induced Uterine Carcinogenesis in Heterozygous p53 Deficient CBA Mice
- Potentials and limitations of nonclinical safety assessment for predicting clinical adverse drug reactions : correlation analysis of 142 approved drugs in Japan